Aprotinin is a bovine pancreatic trypsin inhibitor (BPTI) inhibitor which inhibits trypsin and chymotrypsin with K_is of 0.06 pM and 9 nM, respectively.

Solid

Ki: 0.06 pM (Trypsin), 9 nM (Chymotrypsin)

Aprotinin, a serine protease inhibitor isolated from bovine lung, is a complex protease inhibitor that is an antifibrinolytic, inhibits contact activation, and decreases the inflammatory response to cardiopulmonary bypass. Aprotinin inhibits trypsin (bovine, Ki= 0.06 pM), chymotrypsin (bovine, Ki= 9 nM), plasmin (human, 0.23 nM). Aprotinin is also a competitive protein inhibitor of NOS activity. It inhibits NOS-I and NOS-II with Ki values of 50 μM and 78 μM, respectively. Aprotinin significantly inhibits fibrinolysis with an IC50 of 0.16±0.05 μM.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

High dose aprotinin can reduce blood loss and transfusion requirements associated with primary cardiac procedures such as coronary artery bypass graft (CABG) or heart valve replacement surgery. Aprotinin inhibits thrombus formation in a dose-dependent manner. Aprotinin at a dose of 1.5 mg kg (bolus) and 3 mg kgh infusion (maintenance infusion) causes a tendency towards a reduction in bleeding time. Aprotinin significantly reduces the bleeding time starting at a dose of 3 mg kg bolus plus 6 mg kg h showing a reduction of approximately 84%±2.9%. At the highest dose of 5 mg kg and 10 mg kg h, the strongest effects are observed. Aprotinin may affect tumor necrosis factor-alpha (TNF) levels. Soluble TNFRI levels are significantly increased following I/R in the aprotinin treated wild type mice and not detected in all TNFRInull mice.

Room temperature or refrigerated transport.

sealed storage and away from moisture；Powder； -80°C； 2 years; -20°C； 1 year；

Others

Bovine lung

体外研究:
H₂O : 100 mg/mL(15.36 mM;Need ultrasonic)
DMSO : 66.67 mg/mL(10.24 mM;ultrasonic and adjust pH to 3 with HCl)
配制储存液